Skip to content

Clinical trials

Completed Phase 1/2 Hepatitis C trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 1/2 Status: Completed Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20051
20061
20071
20082
20092
20102
20115
20123
20132
20141
20151
20171
20181
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
National Institute of Allergy and Infectious Diseases (NIAID)3
Beni-Suef University2
ANRS, Emerging Infectious Diseases1
Ain Shams University1
Biolex Therapeutics, Inc.1
Bristol-Myers Squibb1
Can-Fite BioPharma1
Cytheris SA1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C27
Hepatitis C, Chronic7
HIV Infections4
Hepatitis B2
Hepatitis, Chronic2
Virus Diseases2
Carcinoma, Hepatocellular1
Coinfection1
Digestive System Diseases1
Flaviviridae Infections1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.